GreenLight Biosciences Holdings Financials

GreenLight Biosciences Stock Summary

GreenLight Biosciences competes with Alpha Tau. GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid products for human health and agriculture applications. The company was founded in 2008 and is headquartered in Medford, Massachusetts. Greenlight Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.

GreenLight Biosciences Key Financial Ratios

GreenLight Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GreenLight Biosciences's current stock value. Our valuation model uses many indicators to compare GreenLight Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GreenLight Biosciences competition to find correlations between indicators driving GreenLight Biosciences's intrinsic value. More Info.GreenLight Biosciences Holdings is rated # 5 in number of shares shorted category among its peers. It is rated as one of the top companies in revenue category among its peers totaling about  1,333  of Revenue per Number Of Shares Shorted. Comparative valuation analysis is a catch-all technique that is used if you cannot value GreenLight Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

If you are still planning to invest in GreenLight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GreenLight Biosciences' history and understand the potential risks before investing.